Notice: This company has been marked as potentially delisted and may not be actively trading. Salix Pharmaceuticals (SLXP) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029May 17, 2023 | benzinga.comPharmaceuticals NewsApril 6, 2023 | bizjournals.comWhy Salix Pharmaceuticals (SLXP) Stock Is Gaining TodayFebruary 19, 2023 | thestreet.comSalix Pharmaceuticals (SLXP) Stock Closed Lower Today as Valeant Looks to Increase BidJanuary 7, 2023 | thestreet.comWhy Salix Pharmaceuticals (SLXP) Stock Is Soaring TodayDecember 31, 2022 | thestreet.comWhy Salix Pharmaceuticals (SLXP) Stock Is Surging TodayDecember 25, 2022 | thestreet.comValeant Pharmaceuticals (VRX) Stock Surges Today as Analyst Ups Price Target on Salix DealDecember 23, 2022 | thestreet.comBausch Health Says FDA Won't Fully Approve Generic Xifaxan Until 2029September 9, 2022 | marketwatch.comSalix Acquisition Likely, but at What Price Is Open to DebateSeptember 4, 2022 | thestreet.comBausch Health plummets 50% following judge's Xifaxan patent orderJuly 28, 2022 | seekingalpha.comDNDNQ NewsJuly 18, 2022 | thestreet.comSalix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022June 20, 2022 | markets.businessinsider.comJim Cramer's 'Mad Money' Recap: Calm Down, There's No Nasdaq BubbleJune 1, 2022 | thestreet.comStock Market Today: Futures Jump as Jobs Rebound in SeptemberJanuary 6, 2022 | thestreet.comCanada's Valeant to buy Salix in $10.1 billion dealAugust 2, 2021 | finance.yahoo.com Get Salix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SLXP and its competitors with MarketBeat's FREE daily newsletter. Email Address SLXP Media Mentions By Week SLXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLXP News Sentiment▼0.001.17▲Average News Sentiment SLXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLXP Articles This Week▼00▲SLXP Articles Average Week Get Salix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SLXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today ABBV News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today JAZZ News Today CORT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLXP) was last updated on 2/12/2025 by MarketBeat.com Staff From Our PartnersNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Set to Trigger Next AI Boom by February 26?President Trump recently announced this shocking $500 billion initiative to build 20 new AI factories… And ...Brownstone Research | Sponsored$589 billion wiped out overnightYou need to watch this before you invest another cent in AI. Because more than $589 billion was wiped out o...Porter & Company | SponsoredYou’ll remember where you were when you saw this…Elon Musk is heavily invested in a cutting-edge new technology. In fact, Musk has turned the new president ...InvestorPlace | SponsoredElon has entered the MarkBeat conversationSpivey's firm accurately warned of both the 2008 and 2020 stock market crashes and have charged institutional ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salix Pharmaceuticals Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Salix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
